ORIC Pharmaceuticals Inc [ORIC] stock is trading at $11.16, up 4.59%. An important factor to consider is whether the stock is rising or falling in short-term value. The ORIC shares have gain 23.18% over the last week, with a monthly amount glided 13.18%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
ORIC Pharmaceuticals Inc [NASDAQ: ORIC] stock has seen the most recent analyst activity on September 06, 2024, when Stifel initiated its Buy rating and assigned the stock a price target of $20. On September 22, 2023, Wedbush initiated with a Outperform rating and assigned a price target of $8 on the stock. H.C. Wainwright upgraded its rating to a Buy but stick to its price target of $16 on March 23, 2023. Guggenheim upgraded its rating to a Buy but $15 remained the price target by the analyst firm on March 21, 2023. Oppenheimer upgraded its rating to Outperform for this stock on March 16, 2023, but kept the price target unchanged to $14.
ORIC Pharmaceuticals Inc [ORIC] stock has fluctuated between $5.27 and $16.65 over the past year. Currently, Wall Street analysts expect the stock to reach $17 within the next 12 months. ORIC Pharmaceuticals Inc [NASDAQ: ORIC] shares were valued at $11.16 at the most recent close of the market. An investor can expect a potential return of 52.33% based on the average ORIC price forecast.
Analyzing the ORIC fundamentals
Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at -81.35%, Pretax Profit Margin comes in at -72.03%, and Net Profit Margin reading is -72.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.34, Equity is -0.4 and Total Capital is -0.4. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.52 points at the first support level, and at 9.89 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.31, and for the 2nd resistance point, it is at 13.47.
Ratios To Look Out For
For context, ORIC Pharmaceuticals Inc’s Current Ratio is 15.08. On the other hand, the Quick Ratio is 15.08, and the Cash Ratio is 2.55.
Transactions by insiders
Recent insider trading involved Chacko Jacob, PRESIDENT AND CEO, that happened on Mar 06 ’24 when 40000.0 shares were sold. PRESIDENT AND CEO, Chacko Jacob completed a deal on Feb 07 ’24 to sell 26042.0 shares. Meanwhile, PRESIDENT AND CEO Chacko Jacob sold 13958.0 shares on Feb 06 ’24.
